glp-1 drugs depression Comparing Ozempic, Wegovy and Other can glp 1 cause depression
Description
(Views expressed in this opinion piece are those of the author)
placebo on cardiovascular outcomes was tested in 14,752 patients with T2DM, 73% who had cardiovascular disease (299)
The area has a well-developed healthcare infrastructure, major actors are present, the disease prevalence is high, and investments in research and development for novel medications to treat diabetes and obesity are expanding
2014;5(4):e1186
Pharmacotherapy of obesity: an update on the available medications and drugs under investigation
Patients are managing a condition with clear, measurable consequences
